| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |